Drug Profile
SH 7139 companion diagnostic - SHAL Technologies
Alternative Names: SH 7129Latest Information Update: 23 Aug 2023
Price :
$50
*
At a glance
- Originator SHAL Technologies
- Class Diagnostic agents
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Leukaemia; Non-Hodgkin's lymphoma
Most Recent Events
- 23 Aug 2023 Discontinued - Preclinical for Leukaemia (Diagnosis) in USA (unspecified route)
- 23 Aug 2023 Discontinued - Preclinical for Non-Hodgkin's lymphoma (Diagnosis) in USA (unspecified route)
- 28 Aug 2019 No recent reports of development identified for preclinical development in Leukaemia(Diagnosis) in USA